LQDA

Liquidia Corporation NCM · LQDA

$89.03 +1.99 (+2.29%)

Blow-off · +2.10σ Hot zone Grade C

+ Compare Open in Sniper

Valuation

Market cap $7.9B

P/E (ttm) 494.6

Forward P/E 15.3

Beta (5y) 0.55

Shares out 88.9M

Div yield —

Profitability & returns

ROE 28.2%

Net margin 7.7%

FCF margin 3.3%

Debt / equity 1.70

Trading information

Last price $89.03

Day range $85.14 – $90.89

52-wk range $29.12 – $90.89

Avg volume 1.9M

RSI (2) 93.1

Trend zone Blow-off

52-week range · today's price

$29.12$90.89

Company

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange NCM

Next earnings 2026-08-12

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also p…